Schedule 13G ownership disclosure
LYELL IMMUNOPHARMA INC
Common Stock, par value $0.0001 per share · CUSIP: 55083R104
Event date: 2025-07-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Explore Investments LLC
Shares: 1,040,964.00 · Class: 5.4%
- Jeffrey P. Bezos
Shares: 1,040,964.00 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-022288
- Form type
- SCHEDULE 13G
- Filer
- Explore Investments LLC/DE
- CIK
- CIK 2082302
- Filed
- Aug 19, 2025
- Reporting period
- Jul 25, 2025
- Description
- Schedule 13G beneficial ownership